Cordis Sues Boston Scientific Over Stent Patents

By Julie Zeveloff

Law360, New York (January 19, 2010, 5:52 PM ET) -- Johnson & Johnson unit Cordis Corp. has launched a new patent infringement suit against rival Boston Scientific Corp., claiming BSC's Promus drug-eluting stents infringe three patents and unfairly compete with Cordis' Cypher stent sales.

Cordis lodged the suit Friday in the U.S. District Court for the District of Delaware, seeking judgments of infringement, a permanent injunction barring the import and the sale of infringing products, treble damages, and other relief.

According to the complaint, BSC's Promus stents infringe U.S. Patent Numbers 6,086,604; 6,547,817; and 6,716,240, all...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles